Abstract
Aim:
To design novel bifunctional derivatives of huperzine B (HupB) based on the concept of dual binding site of acetylcholinesterase (AChE) and evaluate their pharmacological activities for seeking new drug candidates against Alzheimer's disease (AD).
Methods:
Novel 16-substituted bifunctional derivatives of HupB were synthesized through chemical reactions. The inhibitory activities of the derivatives toward AChE and butyrylcholinesterase (BuChE) were determined in vitro by modified Ellman's method. Cell viability was quantified by the reduction of MTT.
Results:
A new preparative method was developed for the generation of 16-substituted derivatives of HupB, and pharmacological trials indicated that the derivatives were multifunctional cholinesterase inhibitors targeting both AChE and BuChE. Among the derivatives tested, 9c, 9e, 9f, and 9i were 480 to 1360 times more potent as AChE inhibitors and 370 to 1560 times more potent as BuChE inhibitors than the parent HupB. Further preliminary pharmacological trials of derivatives 9c and 9i were performed, including examining the mechanism of AChE inhibition, the substrate kinetics of the enzyme inhibition, and protection against hydrogen peroxide (H2O2)-induced cytotoxicity in PC12 cells.
Conclusion:
Preliminary pharmacological evaluation indicated that 16-substituted derivatives of HupB, particularly 9c and 9i, would be potentially valuable new drug candidates for AD therapy, and further exploration is needed to evaluate their pharmacological and clinical efficacies.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Goedert M, Spillantini MG . A century of Alzheimer's disease. Science 2006; 314: 777–81.
Youdim MB, Buccafusco JJ . Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders. Trends Pharmacol Sci 2005; 26: 27–35.
Francis PT, Nordberg A, Arnold SE . A preclinical view of cholinesterase inhibitors in neuroprotection: do they provide more than symptomatic benefits in Alzheimer's disease? Trends Pharmacol Sci 2005; 26: 104–11.
Francotte P, Graindorge E, Boverie S, de Tullio P, Pirotte B . New trends in the design of drugs against Alzheimer's disease. Curr Med Chem 2004; 11: 1757–78.
Ji HF, Zhang HY . Multipotent natural agents to combat Alzheimer's disease. Functional spectrum and structural features. Acta Pharmacol Sin 2008; 29: 143–51.
Inestrosa NC, Alvarez A, Perez CA, Moreno RD, Vicente M, Linker C, et al. Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme. Neuron 1996; 16: 881–91.
Bartolini M, Bertucci C, Cavrini V, Andrisano V . beta-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies. Biochem Pharmacol 2003; 65: 407–16.
Munoz-Torrero D, Camps P . Dimeric and hybrid anti-Alzheimer drug candidates. Curr Med Chem 2006; 13: 399–422.
Castro A, Martinez A . Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitors. Curr Pharm Des 2006; 12: 4377–87.
Liu J, Zhu YL, Yu CM, Zhou YZ, Han YY, Wu FW, et al. The structure of huperzine A and B, two new alkaloids exhibiting marked anti-cholinesterase activity. Can J Chem 1986; 64: 837–9.
Bai DL, Tang XC, He XC . Huperzine A, a potential therapeutic agent for treatment of Alzheimer's disease. Curr Med Chem 2000; 7: 355–74.
Jiang H, Luo X, Bai D . Progress in clinical, pharmacological, chemical and structural biological studies of huperzine A: a drug of traditional chinese medicine origin for the treatment of Alzheimer's disease. Curr Med Chem 2003; 10: 2231–52.
Yan XF, Lu WH, Lou WJ, Tang XC . Effects of huperzine A and B on skeletal muscle and the electroencephalogram. Acta Pharmacol Sin 1987; 8: 117–23.
Zhu XD, Tang XC . Improvement of impaired memory in mice by huperzine A and huperzine B. Acta Pharmacol Sin 1988; 9: 492–7.
Xu H, Tang XC . Cholinesterase inhibition by huperzine B. Acta Pharmacol Sin 1987; 8: 18–22.
Liu J, Zhang HY, Wang LM, Tang XC . Inhibitory effects of huperzine B on cholinesterase activity in mice. Acta Pharmacol Sin 1999; 20: 141–5.
Wang ZF, Zhou J, Tang XC . Huperzine B protects rat pheochromocytoma cells against oxygen-glucose deprivation-induced injury. Acta Pharmacol Sin 2002; 23: 1193–8.
Feng S, Wang Z, He X, Zheng S, Xia Y, Jiang H, et al. Bis-huperzine B: highly potent and selective acetylcholinesterase inhibitors. J Med Chem 2005; 48: 655–7.
Feng S, Xia Y, Han D, Zheng C, He X, Tang X, et al. Synthesis and acetylcholinesterase inhibition of derivatives of huperzine B. Bioorg Med Chem Lett 2005; 15: 523–6.
He XC, Feng S, Wang ZF, Shi Y, Zheng S, Xia Y, et al. Study on dual-site inhibitors of acetylcholinesterase: Highly potent derivatives of bis- and bifunctional huperzine B. Bioorg Med Chem 2007; 15: 1394–408.
Dvir H, Jiang HL, Wong DM, Harel M, Chetrit M, He XC, et al. X-ray structures of Torpedo californica acetylcholinesterase complexed with (+)-huperzine A and (–)-huperzine B: structural evidence for an active site rearrangement. Biochemistry 2002; 41: 10810–8.
Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM . A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961; 7: 88–95.
Bhattacharyya S . Reductive alkylation of dimethylamine using titanium (IV) isopropoxide and sodium borohydride: an efficient, safe and convenient method for synthesis of N,N-dimethylated tertiary amines. J Org Chem 1995; 60: 4928–9.
Zhang HY, Tang XC . Huperzine B, a novel acetylcholinesterase inhibitor, attenuates hydrogen peroxide induced injury in PC12 cells. Neurosci Lett 2000; 292: 41–4.
Bolognesi ML, Cavalli A, Valgimigli L, Bartolini M, Rosini M, Andrisano V, et al. Multi-target-directed drug design strategy: from a dual binding site acetylcholinesterase inhibitor to a trifunctional compound against Alzheimer's disease. J Med Chem 2007; 50: 6446–9.
Du DM, Carlier PR . Development of bivalent acetylcholinesterase inhibitors as potential therapeutic drugs for Alzheimer's disease. Curr Pharm Des 2004; 10: 3141–56.
Holzgrabe U, Kapkova P, Alptuzun V, Scheiber J, Kugelmann E . Targeting acetylcholinesterase to treat neurodegeneration. Expert Opin Ther Targets 2007; 11: 161–79.
Wang R, Yan H, Tang XC . Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine. Acta Pharmacol Sin 2006; 27: 1–26.
Giacobini E . Cholinesterase inhibitors: new roles and therapeutic alternatives. Pharmacol Res 2004; 50: 433–40.
Savini L, Gaeta A, Fattorusso C, Catalanotti B, Campiani G, Chiasserini L, et al. Specific targeting of acetylcholinesterase and butyrylcholinesterase recognition sites. Rational design of novel, selective, and highly potent cholinesterase inhibitors. J Med Chem 2003; 46: 1–4.
Rosini M, Andrisano V, Bartolini M, Bolognesi ML, Hrelia P, Minarini A, et al. Rational approach to discover multipotent anti-Alzheimer drugs. J Med Chem 2005; 48: 360–3.
Decker M . Homobivalent quinazolinimines as novel nanomolar inhibitors of cholinesterases with dirigible selectivity toward butyrylcholinesterase. J Med Chem 2006; 49: 5411–3.
Rodriguez-Franco MI, Fernandez-Bachiller MI, Perez C, Castro A, Martinez A . Design and synthesis of N-benzylpiperidine-purine derivatives as new dual inhibitors of acetyl- and butyrylcholinesterase. Bioorg Med Chem 2005; 13: 6795–802.
Piazzi L, Belluti F, Bisi A, Gobbi S, Rizzo S, Bartolini M, et al. Cholinesterase inhibitors: SAR and enzyme inhibitory activity of 3-[omega-(benzylmethylamino)alkoxy]xanthen-9-ones. Bioorg Med Chem 2007; 15: 575–85.
Gilgun-Sherki Y, Melamed E, Offen D . Antioxidant treatment in Alzheimer's disease: current state. J Mol Neurosci 2003; 21: 1–11.
Markesbery WR . Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 1997; 23: 134–47.
Acknowledgements
This project was supported by the National Natural Science Foundation of China (Grant No 30472067) and Shanghai SK Foundation for Research and Development (Project No 2004010-h).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Shi, Yf., Zhang, Hy., Wang, W. et al. Novel 16-substituted bifunctional derivatives of huperzine B: multifunctional cholinesterase inhibitors. Acta Pharmacol Sin 30, 1195–1203 (2009). https://doi.org/10.1038/aps.2009.91
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/aps.2009.91
Keywords
This article is cited by
-
Retrospect and prospect of active principles from Chinese herbs in the treatment of dementia
Acta Pharmacologica Sinica (2010)
